Why Medical Properties Trust (MPT) is back in focus Recent reports of a 7.8% share price drop in Medical Properties Trust (MPT), a negative Altman Z-Score and insider selling over the past 3 months ...

So-called “facility fees” charged to patients at hospital-owned outpatient clinics prompted a spirited debate Tuesday before ...

Tirzepatide, which is marketed as Zepbound for chronic weight management, is a dual GIP and GLP-1 receptor agonist that has ...

A new analysis of Medicare data shows mental health specialists who embraced telehealth did not see substantially more rural patients ...

The FDA is targeting telehealth marketing of GLP-1 drugs. But those companies may not be the only ones under the microscope.

Researchers in China have developed magnetically controlled microrobots made from diatoms for the treatment of glioblastoma using photodynamic therapy. These microrobots exhibit excellent magnetic ...

On a typical day, they greet farmers bringing them ticks, real estate agents with mysterious roaches and anxious homeowners ...

For Shaw, the fight against drug-resistant bacteria is personal. Growing up in England, he developed a chronic staph infection after hip surgery as a teenager. The infection, caused by ...

The Ravens' and Raiders' plans are in the shredder. Maxx Crosby's knee is under a microscope. And the Cowboys are being the ...

Breast cancer grade (1-3) isn't the only factor determining treatment or outcome – other factors, such as stage and genetic markers, also play a role.

BridgeBio Pharma (NASDAQ:BBIO) highlighted accelerating U.S. uptake for its transthyretin (TTR) stabilizer Attruby and laid out key timelines for upcoming launches and pipeline programs during a ...

Hemorrhage is the leading preventable cause of death after trauma, accounting for roughly one-third of all trauma-related fatalities. It doesn’t matter if it’s a shrapnel wound on a battlefield, a ...